Literature DB >> 25924768

Comparison of Two Commercial Tick-Borne Encephalitis Virus IgG Enzyme-Linked Immunosorbent Assays.

Fabian H Weissbach1, Hans H Hirsch2.   

Abstract

Despite the availability of protective vaccines, tick-borne encephalitis virus (TBEV) infections have been increasingly reported to the European Centre for Disease Prevention and Control in the past 2 decades. Since the diagnosis of TBEV exposure relies on serological testing, we compared two commercial enzyme-linked immunosorbent assays (ELISAs), i.e., Immunozym FSME IgG assay (ELISA-1) and Euroimmun FSME Vienna IgG assay (ELISA-2). Both assays use whole TBEV antigens, but they differ in viral strains (Neudoerfl for ELISA-1 and K23 for ELISA-2) and cutoff values. In testing of samples from 398 healthy blood donors, ELISA-1 showed higher reactivity levels than ELISA-2 (P < 0.001), suggesting different assay properties. This finding was supported by Bland-Altman analysis of the optical density at 450 nm (OD450) (mean bias, +0.32 [95% limits of agreement, -0.31 to +0.95]) and persisted after transformation into Vienna units. Concordant results were observed for 276 sera (69%) (44 positive and 232 negative results). Discordant results were observed for 122 sera (31%); 15 were fully discordant, all being ELISA-1 positive and ELISA-2 negative, and 107 were partially discordant (101 being ELISA-1 indeterminate and ELISA-2 negative and 6 having positive or indeterminate reactivity in both ELISAs). Neutralization testing at a 1:10 dilution yielded positive results for 33 of 44 concordant positive sera, 1 of 15 fully discordant sera, and 1 of 33 partially discordant sera. Indirect immunofluorescence testing revealed high antibody titers of ≥100 for yellow fever virus in 18 cases and for dengue virus in one case, suggesting that cross-reactivity contributed to the ELISA-1 results. We conclude that (i) cross-reactivity among flaviviruses remains a limitation of TBEV serological testing, (ii) ELISA-2 revealed reasonable sensitivity and specificity for anti-TBEV IgG population screening of human sera, and (iii) neutralization testing is most specific and should be reserved for selective questions.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25924768      PMCID: PMC4478524          DOI: 10.1128/CVI.00096-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  22 in total

1.  West Nile virus outbreak in humans, Greece, 2012: third consecutive year of local transmission.

Authors:  D Pervanidou; M Detsis; K Danis; K Mellou; E Papanikolaou; I Terzaki; A Baka; L Veneti; A Vakali; G Dougas; C Politis; K Stamoulis; S Tsiodras; T Georgakopoulou; A Papa; A Tsakris; J Kremastinou; C Hadjichristodoulou
Journal:  Euro Surveill       Date:  2014-04-03

2.  Evaluation of different serological diagnostic methods for tick-borne encephalitis virus: enzyme-linked immunosorbent, immunofluorescence, and neutralization assay.

Authors:  Nadine Litzba; Hana Zelená; Thomas R Kreil; Bo Niklasson; Ilona Kühlmann-Rabens; Maria Elena Remoli; Matthias Niedrig
Journal:  Vector Borne Zoonotic Dis       Date:  2013-12-20       Impact factor: 2.133

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Prevalence of antibodies to Borrelia burgdorferi and tick-borne encephalitis virus in an endemic region in southern Germany.

Authors:  R Kaiser; A Kern; D Kampa; D Neumann-Haefelin
Journal:  Zentralbl Bakteriol       Date:  1997-11

5.  A model of laboratory surveillance for neuro-arbovirosis applied during 2012 in the Emilia-Romagna region, Italy.

Authors:  A Pierro; M P Landini; P Gaibani; G Rossini; C Vocale; A C Finarelli; R Cagarelli; V Sambri; S Varani
Journal:  Clin Microbiol Infect       Date:  2013-12-12       Impact factor: 8.067

6.  ELISA for IgM and IgG antibodies against tick-borne encephalitis virus: quantification and standardization of results.

Authors:  H Hofmann; F X Heinz; H Dippe
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-11

7.  Ixodes ricinus and Borrelia prevalence at the Arctic Circle in Norway.

Authors:  Dag Hvidsten; Snorre Stuen; Andrew Jenkins; Olaf Dienus; Renate S Olsen; Bjørn-Erik Kristiansen; Reidar Mehl; Andreas Matussek
Journal:  Ticks Tick Borne Dis       Date:  2013-11-18       Impact factor: 3.744

Review 8.  Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe.

Authors:  Jolyon M Medlock; Kayleigh M Hansford; Antra Bormane; Marketa Derdakova; Agustín Estrada-Peña; Jean-Claude George; Irina Golovljova; Thomas G T Jaenson; Jens-Kjeld Jensen; Per M Jensen; Maria Kazimirova; José A Oteo; Anna Papa; Kurt Pfister; Olivier Plantard; Sarah E Randolph; Annapaola Rizzoli; Maria Margarida Santos-Silva; Hein Sprong; Laurence Vial; Guy Hendrickx; Herve Zeller; Wim Van Bortel
Journal:  Parasit Vectors       Date:  2013-01-02       Impact factor: 3.876

9.  Vaccination and tick-borne encephalitis, central Europe.

Authors:  Franz X Heinz; Karin Stiasny; Heidemarie Holzmann; Marta Grgic-Vitek; Bohumir Kriz; Astrid Essl; Michael Kundi
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

10.  Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals.

Authors:  Pontus Lindblom; Peter Wilhelmsson; Linda Fryland; Andreas Matussek; Mats Haglund; Johanna Sjöwall; Sirkka Vene; Dag Nyman; Pia Forsberg; Per-Eric Lindgren
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.